drugset / Trial / NCT02665689
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Phase 4
Terminated
4 enrolled
Prof. Dr. Antonia M. Joussen
Charite University, Berlin, Germany · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the prospective randomized study is to investigate whether a intensified diabetic control program leads to better final visual acuity and less frequent diabetic ocular complications in patients with diabetic retinopathy when compared with a normal diabetic treatment.
Timeline
- Start
- 2016-01-18
- Primary completion
- 2018-09-07
- Completion
- 2018-09-07
Outcome
Outcome not reported
Stopped (Enrollment): “Enrollment pace was far below target.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |